This 775-page seven-country study is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
Rationale
During the next five years, the transfusion diagnostics market will undergo significant transformation, which will result from the convergence of several trends, including more stringent regulations; advances in diagnostic technologies, IT, system engineering and automation; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and differentiation are more critical than underlying technology.The changes in the marketplace will create exciting opportunities for new instruments and reagent systems, as well as auxiliary products, such as specimen preparation devices, controls, calibrators, and innovative IT applications.
Geographic Coverage
- France, Germany, Italy, Japan, Spain, UK, USA
Sales and Market Share Analysis
Sales and market share estimates for leading suppliers of transfusion diagnostic testing reagents and instruments, by country and individual product.Instrument Placements
Annual placements and installed base of major automated and semi-automated analyzers, by supplier and model.Competitive Assessments
Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.Market Segmentation Analysis
- Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers, by country.
- Test volume and sales forecasts for over 40 transfusion diagnostic tests, including NAT, by country and market segment:
Current and Emerging Products
- Analysis of current and emerging transfusion diagnostic tests.
- Review of automated and semi-automated analyzers, including their operating characteristics, features, and selling prices.
Technology Review
- Assessment of current and emerging technologies, and their potential applications for the transfusion diagnostics market.
- Comprehensive lists of companies developing or marketing new technologies and products, by test.
Worldwide Market Overview
- Estimates of facilities performing transfusion diagnostic tests, by country.
- Test volume and sales projections by country.
Strategic Recommendations
- New product development opportunities with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Methodology
The report is based on combination of primary and secondary information sources, including interviews with blood bankers, laboratory directors, and executives of leading diagnostics companies in the U.S., five major European countries, and Japan.In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as proprietary data files was conducted.
Companies Mentioned
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher
